Ed Seguine CEO of Clinical Ink Talks About Hybrid Clinical Trials During and Post COVID-19 | S2 E20

May 6, 2020 | Digital Media, Podcast

Ed Seguine

Ed Seguine, CEO of #ClinicalInk, talks about how hybrid trials, #BYOD ePRO, and DDC can provide a valuable solution during a healthcare crisis like #COVID19.

You can learn more about Ed Seguine and Clinical Ink here

0 Comments

Pin It on Pinterest